Menveo Ad Should Not List CDC Recommendations Because It Does Not Meet Them, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The approved use of Novartis' meningococcal disease vaccine does not match up with CDC recommendations, FDA says in a letter to the company.
You may also be interested in...
Forget Twitter – Telephone Script Also Snags FDA Citation
Office of Prescription Drug Promotion objects to Concordia’s telephone script for attention deficit hyperactivity disorder drug Kapvay.
Drug Ads Should Take A Long View, DDMAC Says In Citing Time-To-Onset Claims
FDA sends notice of violation letters to Dow Pharmaceutical Sciences (Valeant) and Novartis for stretching a point in promotional materials for Acanya Gel and Focalin XR, respectively.
Drug Ads Should Take A Long View, DDMAC Says In Citing Time-To-Onset Claims
FDA sends notice of violation letters to Dow Pharmaceutical Sciences (Valeant) and Novartis for stretching a point in promotional materials for Acanya Gel and Focalin XR, respectively.